Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1901172 | 0.86 | ALDH1A1 (0.76) | ALDH1A1HSD17B10CYP1A2RAB9APOLB | |
| SCHEMBL12129057 | 0.82 | ALDH1A1 (0.67) | ALDH1A1HSD17B10CYP1A2TP53MAPT | |
| SCHEMBL3901564 | 0.81 | KMT2A (0.60) | ALDH1A1CYP1A2RAB9APOLBL3MBTL1 | |
| SCHEMBL27392287 | 0.81 | GAA (0.47) | ALDH1A1MAPT | |
| SCHEMBL10705800 | 0.81 | TP53 (0.56) | TP53TSHR | |
| SCHEMBL1176396 | 0.80 | SMN1; SMN2 (0.61) | ALDH1A1HSD17B10RAB9APOLBL3MBTL1 | |
| SCHEMBL1487964 | 0.79 | ALDH1A1 (0.66) | ALDH1A1HSD17B10CYP1A2RAB9APOLB | |
| SCHEMBL4714652 | 0.79 | HSD17B10 (0.71) | ALDH1A1HSD17B10CYP1A2RAB9APOLB | |
| SCHEMBL527866 | 0.78 | ALDH1A1 (0.59) | ALDH1A1HSD17B10CYP1A2RAB9APOLB | |
| SCHEMBL19200618 | 0.77 | ALDH1A1 (0.54) | ALDH1A1HSD17B10CYP1A2RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109593384-B | Preparation method of pre-dispersed pigment for offset printing ink | 宇虹颜料股份有限公司 | 2020-09-25 | — | — | CN | disclosed |
| US-9618867-B2 | Pigment dispersion and toner | CANON KABUSHIKI KAISHA (JP) | 2017-04-11 | — | — | US | disclosed |
| US-8115027-B2 | NPY Y5 antagonist | SHIONOGI & CO., LTD. (JP) | 2012-02-14 | — | — | US | disclosed |
| US-20100292500-A1 | NPY Y5 ANTAGONIST | KAWANISHI YASUYUKI | 2010-11-18 | — | — | US | disclosed |
| EP-2014285-A1 | NPYY5 antagonists | Shionogi&Co., Ltd. (JP) | 2009-01-14 | — | — | EP | disclosed |
| US-7303589-B2 | Process for dyeing human keratin fibers, having a lightening effect, comprising at least one fluorescent compound and compositions of the same | L'OREAL S.A. (FR) | 2007-12-04 | — | — | US | disclosed |
| US-7265130-B2 | NPY Y5 antagonist | SHIONOGI & CO., LTD. (JP) | 2007-09-04 | — | — | US | disclosed |
| US-7250064-B2 | Dye composition comprising at least one fluorescent dye and a non-associative thickening polymer for human keratin materials, process therefor, and method thereof | L'OREAL S.A. (FR) | 2007-07-31 | — | — | US | disclosed |
| US-7208018-B2 | Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one associative polymer, process therefor and use thereof | L'OREAL (FR) | 2007-04-24 | — | — | US | disclosed |
| US-7204860-B2 | Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one polyol, process therefor and use thereof | L'OREAL (FR) | 2007-04-17 | — | — | US | disclosed |
| US-7198650-B2 | Method of dyeing human keratin materials with a lightening effect with compositions comprising at least one fluorescent dye and at least one amphoteric or nonionic surfactant, composition thereof, process thereof, and device therefor | L'OREAL S.A. (FR) | 2007-04-03 | — | — | US | disclosed |
| EP-1622581-B1 | DYEING METHOD FOR HUMAN KERATINOUS FIBERS WITH LIGHTENING EFFECT, PARTICULAR FLUORESCENT COMPOUND AND COMPOSITION COMPRISING SAME | OREAL (FR) | 2007-03-28 | — | — | EP | disclosed |
| US-7195651-B2 | Cosmetic composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one cationic polymer, and a dyeing process therefor | L'OREAL S.A. (FR) | 2007-03-27 | — | — | US | disclosed |
| US-7195650-B2 | Process for dyeing, with a lightening effect, human keratin fibers that have been permanently reshaped, using at least one composition comprising at least one fluorescent dye | L'OREAL S.A. (FR) | 2007-03-27 | — | — | US | disclosed |
| US-7192454-B2 | Composition for dyeing human keratin materials, comprising a fluorescent dye and a particular sequestering agent, process therefor and use thereof | L'OREAL S.A. (FR) | 2007-03-20 | — | — | US | disclosed |
| US-7186278-B2 | Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one compound comprising an acid functional group and processes therefor | L'OREAL S.A. (FR) | 2007-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292500-A1 | NPY Y5 ANTAGONIST | NPY5R, NPY1R, NPY2R | ALDH1A1 4599/4885HSD17B10 1102/4885CYP1A2 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.